Study shows liraglutide results in increased insulin sensitivity independent of weight loss

A new study demonstrates that a glucagon-like peptide-1 receptor (GLP-1R) agonist, a member of a class of medication used to treat Type 2 diabetes and obesity, can lead to a rapid improvement in insulin sensitivity.

Click here to access the article.